Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs ProShares UltraPro S&P500 (UPRO) Price & Performance

Kenvue Inc. Common StockTrade
ProShares UltraPro S&P500Trade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs ProShares UltraPro S&P500 — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while ProShares UltraPro S&P500 trades at $155.76 (market cap $5.55B). The key difference: Kenvue Inc. Common Stock is far larger — about 6.1× ProShares UltraPro S&P500's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while ProShares UltraPro S&P500 pays none. Which is the better fit depends on your goals.

KVUEUPRO
Market Cap
$34.06B$5.55B
Volume
23,267,2282,078,694
Sector
Consumer StaplesLeveraged / Inverse
52-Week High
$19.83$157.66
52-Week Low
$14.11$89.29
Enterprise Value
$41.56B—
Dividend Yield
4.74%—
Typical Hold Time
—29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

No Aura AI signal available yet.

ProShares UltraPro S&P500

UPRO trades at $155.73, up 0.34% today, with a bullish technical signal from moving averages and neutral oscillators. The stock faces resistance near $157 and support at $151. Key financial ratios are not available in the provided data, limiting fundamental assessment. A dividend of $0.27 is scheduled for September 2026.

The outlook is cautiously optimistic due to bullish technical trends, but the absence of fundamental metrics like P/E and ROE increases reliance on market sentiment. Risks include S&P 500 volatility and profit growth concerns highlighted in recent news. Investors should seek updated financials for a complete view.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About ProShares UltraPro S&P500

UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.

Read more on UPRO →